Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose oxytocin for augmentation of labor
ACTRN12610000900011Phase 2Not yet recruiting
- Sponsor
- Suppasiri Hayakungchat
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxytocin in labor dystocia (2 arms), sponsored by Suppasiri Hayakungchat. Primary endpoint: Cesarean section rate. Planned start Nov 2010; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
labor dystocia
Beyond the preview
Go deeper on ACTRN12610000900011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000900011.